by Cort Johnson | Jun 4, 2019 | Homepage, Montoya
Eleven years ago, Dr. Jose Montoya bucked his mentor’s advice to stay away from ME/CFS at all costs. In 2008, he made history by opening one of the first chronic fatigue syndrome (ME/CFS) clinic/research centers at a top university. While the promise of his...
by Cort Johnson | May 29, 2019 | Cervical Stenosis, Cervical Stenosis, Craniocervical Instability, Rowe, Spine, Spine
The Spinal Series This is part three of a series examining spinal issues which may mimic chronic fatigue syndrome (ME/CFS) and fibromyalgia. The first two in the series involved two very ill ME/CFS patients who have recovered or are recovering following surgery to...
by Cort Johnson | May 23, 2019 | Coping, Finances, Homepage
Neglect is embedded in our history. It’s hard to have a conversation without someone mentioning the neglected funding, the doctors who don’t get it, the lack of treatments, the unheeding friends or family; i.e. the things we as a community don’t have...
by Cort Johnson | May 21, 2019 | Brainstem, Craniocervical Instability, Craniocervical Instability, Homepage, Spine
Jennifer Brea is the second person so far to recover from chronic fatigue syndrome (ME/CFS), POTS, mast cell activation syndrome (MCAS) following surgery to correct craniocervical instability - a condition caused by weak ligaments which cause the head to impact the brainstem.
by Cort Johnson | May 17, 2019 | Ampligen, Cortene, Dextromethorphan, Electromagnetic Radiation, Flexeril, Homepage, Ivabradine, Ketamine, Lyrica, Metformin, Mifepristone, Stimulants, Suramin, Tomnya, Treatment
Not satisfied with how your treatments for fibromyalgia and/or chronic fatigue syndrome (ME/CFS) is going? Look to the future at the drugs trials underway in both these diseases as well as other trials in other diseases that may help.
by Cort Johnson | May 14, 2019 | Fibromyalgia, Homepage, Sleep
With its ability to help with both sleep and pain in fibromyalgia, TNX-102 or Tomnya, could hit the sweet spot for FM. It would also break the string of drug misses in the disease if approved by the FDA.